Background: Ku Dou Zi is the dried whole plant, roots and seeds of Sophora alopecuroides L. in the genus Sophora of family Leguminosae. The
Introduction
Ku Dou Zi is the dried whole plant, roots and seeds of Sophora alopecuroides L. in the genus Sophora of family Leguminosae. The entire plant is bitter in taste, cold in nature, and has the heat clearing, detoxifying, pathogenic wind dispelling, dampness removing, analgesic, and insecticidal effects (Yang et al., 1998) . Modern pharmacological studies have proved that TASA not only has pharmacological activities of anti-cancer suppression and killing of various microorganisms, but also possesses a wide range of pharmacological effects on immune system, nervous system, and cardiovascular system (Dong et al., 2005; Liang et al., 2008; Qiu et al., 2007; Qiu et al., 2002) . This study investigated the inhibitory effect of TASA on osteosarcoma cell growth and its mechanism mainly by MTT assay and flow cytometry.
Materials and methods

Main reagents and instruments
MTT reagent (Sigma-Aldrich); automatic microplate reader (BIO 128); flow cytometer (FACSCalibur, BD Biosciences, USA); 5% CO 2 incubator, purchased from Heraeus, USA.
Drugs and experimental tumor strains
Total alkaloids of sophora alopecuroides (Wuhan Dinghui Chemical Co., Ltd., calculated by dry base, matrine content was calculated by oxymatrine as 92%, batch number: 200013658); human osteosarcoma cell line OS732, purchased from Institute of Orthopedics of Beijing Jishuitan Hospital.
Animals
Kunming mice, male, weighing between 18-22g, were purchased from the China Medical University, and adaptively fed for 4, days. All experimental procedures were approved by the Animal Research Ethics Committee of Xinxiang Medical College University.
Cell culturing
OS732, cells were cultured in RPME 1640, medium containing 15%, mycoplasma-free inactivated FBS, and incubated in a CO 2 incubator set at 37℃, 5% CO 2 with 100% humidity. Cells were maintained in the logarithmic growth phase and set aside.
Inhibition of OS732 osteosarcoma cells by TASA (MTT assay)
The logarithmic-growth-phase cells were digested, collected, and adjusted to a single cell suspension with a concentration of 5 × 10 4 /ml, then seeded in 96-well plates, 24hrs later, TASA which was prepared in RPMI 1640, medium having final concentrations of 1.5g/kg, 3g/kg, and 4.5g/kg were added, respectively. Five replicate wells were set up for each concentration, on the 3rd day, 30μL of MTT solution (5g·L
), was added to each well, and the incubation was continued for another 4hrs, then the supernatant was discarded, DMSO was added, and the plates were shaken for 10min., then the absorbance (A), of each well was measured at 570nm.
Inhibition rate = (A value of negative control group -A value of experimental group), / A value of negative control group × 100%.
Flow cytometry (FCM) analysis
A total of 1×10 6 OS732, osteosarcoma cells treated by 1.5g/kg, 3g/kg, and 4.5g/kg TASA, were collected, washed with PBS, fixed in ethanol, and allowed to stand overnight at 4℃, detection was performed by conventional PI staining, and apoptotic cell proportion was analyzed by FEM.
Statistical analysis
Experimental data were expressed as x -±s, and were processed by analysis of variance using SPSS11 statistical software.
Results
Inhibitory effect of TASA on OS732 cell growth
Compared with the control group, each dose groups of TASA significantly (P<0.05), inhibited OS732, cell growth, and there were clear dose-effect relationships between inhibitory effect and drug concentration (see Table 1 ). Table 2 ). 
Observation of cell morphological changes under optical microscope
Each TASA dose group could induce apoptosis; manifestations were: integrated cell membrane structure; cell shrinkage; nuclear fragmentation; after chromatin condensation of apoptotic cells, density increased, and volume diminished. Meanwhile, organelles maintained intact shape, showing the typical apoptotic features (Figures 1, 2 ). 
Discussion
Osteosarcoma is a malignant osteogenic tumor, and the overall incidence of osteosarcoma accounts for about 0.2%, of all human malignant solid tumors. Osteosarcoma is commonly treated using alkylating agents, their efficiency is about 15%, and the overall curative efficacy is unstable (Niu et al., 2010; Li et al., 2004) . At present, surgery-based comprehensive treatments are generally adopted for the treatment of osteosarcoma, including chemotherapy, and radiotherapy. The exploration of anti-osteosarcoma effects of Chinese medicines, and their mechanisms are of great significance for enriching clinical medication, as well as reducing the burden and pain of patients.
This study found by MTT assay that TASA had an apparent inhibitory effect on proliferation rate of human osteosarcoma OS732, cells 
